Microbix Biosystems Inc.

MBX.TOTSXHealthcare● Active

$0.27

+$0.00(+0.00%)

Market Cap$37409310

P/E Ratio—

52W High$0.34

52W Low$0.21

Avg Volume59K

Open$0.28

Beta0.57

Net Income Financials Revenue

Microbix Biosystems Inc. (MBX.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MBX.TO · net income · updated Jun 9, 2026

Core profitability metrics

MBX.TO · net income · margin · TTM · CAGR

Net income was −$2.2M for FY2025 (fiscal year ending 2025-09-30), down 163.8% year-over-year. Net profit margin was -12.1%. Based on available data, Microbix Biosystems Inc. has been profitable since at least 2013.

FY2025 Net Income−$2.2M▼ -163.8% YoY

Trailing 12M (TTM)−$5.7Mtrailing 4 quarters sum

Net Profit Margin-12.1%−$2.2M ÷ $18.6M

YoY Change-163.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · MBX.TO net income history · MBX.TO profit margin

Annual net income data

MBX.TO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$2.2M▼ 163.8%-12.1%$18.6M

FY2024$3.5M▲ +9015.7%13.9%$25.4M

FY2023Loss−$39,483▼ 102.2%-0.2%$16.5M

FY2022$1.8M▲ +9.7%9.4%$19.1M

FY2021$1.6M▲ +126.2%8.8%$18.6M

Net income vs peers (Healthcare)

MBX.TO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Microbix Biosystems Inc.YOU

MBX.TO

−$2.2M-163.8%-12.1%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Microbix Biosystems Inc. (MBX.TO) reported net income of −$2.2M for FY2025 (fiscal year ending 2025-09-30), down 163.8% year-over-year. The net profit margin was -12.1% — meaning the company kept $-0.12 of every dollar of revenue as profit.

Based on available data, Microbix Biosystems Inc. has been profitable since at least 2013. Net income reached a peak of $3.5M in FY2024. Data available for 15 fiscal years.

Microbix Biosystems Inc.'s net profit margin was -12.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Microbix Biosystems Inc. net worth" — the company's market capitalization is a separate figure from MBX.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

MBX.TO net income · 4 questions

Microbix Biosystems Inc. is not currently profitable on an annual basis. The company reported a net loss of $2.2M for FY2025.

is MBX.TO profitabledoes MBX.TO make a profitMBX.TO profitabilityMBX.TO profitable company

▸ Source: FMP /income-statement · GAAP · Microbix Biosystems Inc. · Microbix Biosystems Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026